108 related articles for article (PubMed ID: 23441861)
1. Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1.
Winum JY; Capasso C
Expert Opin Ther Pat; 2013; 23(6):757-60. PubMed ID: 23441861
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.
Battke C; Kremmer E; Mysliwietz J; Gondi G; Dumitru C; Brandau S; Lang S; Vullo D; Supuran C; Zeidler R
Cancer Immunol Immunother; 2011 May; 60(5):649-58. PubMed ID: 21298264
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
Poulsen SA
Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
[TBL] [Abstract][Full Text] [Related]
4. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
Nocentini A; Supuran CT
Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
Lomelino C; McKenna R
Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human carbonic anhydrase XII stability and inhibitor binding.
Jogaitė V; Zubrienė A; Michailovienė V; Gylytė J; Morkūnaitė V; Matulis D
Bioorg Med Chem; 2013 Mar; 21(6):1431-6. PubMed ID: 23159038
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: an editorial.
Supuran CT
Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.
Gondi G; Mysliwietz J; Hulikova A; Jen JP; Swietach P; Kremmer E; Zeidler R
Cancer Res; 2013 Nov; 73(21):6494-503. PubMed ID: 24030978
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action.
Puscas I; Ifrim M; Maghiar T; Coltau M; Domuta G; Baican M; Hecht A
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):265-70. PubMed ID: 11430635
[TBL] [Abstract][Full Text] [Related]
14. Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines.
Winum JY; Carta F; Ward C; Mullen P; Harrison D; Langdon SP; Cecchi A; Scozzafava A; Kunkler I; Supuran CT
Bioorg Med Chem Lett; 2012 Jul; 22(14):4681-5. PubMed ID: 22721713
[TBL] [Abstract][Full Text] [Related]
15. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).
Carta F; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):681-91. PubMed ID: 23488823
[TBL] [Abstract][Full Text] [Related]
16. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
17. Sulfonamides: a patent review (2008 - 2012).
Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2012 Jul; 22(7):747-58. PubMed ID: 22697257
[TBL] [Abstract][Full Text] [Related]
18. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
Masini E; Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
[TBL] [Abstract][Full Text] [Related]
19. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro.
Parkkila S; Rajaniemi H; Parkkila AK; Kivela J; Waheed A; Pastorekova S; Pastorek J; Sly WS
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2220-4. PubMed ID: 10688890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
